REPLIGEN CORP — Director's Dealing 2021

Mar 13, 2021

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: REPLIGEN CORP (RGEN)
CIK: 0000730272
Period of Report: 2021-03-10

Reporting Person: KURIYEL RALF (Senior VP, R&D)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2021-03-10	Common Stock	M	2000	$33.05	Acquired	27265	Direct
2021-03-10	Common Stock	M	5850	$33.87	Acquired	33115	Direct
2021-03-10	Common Stock	M	150	$59.52	Acquired	33265	Direct
2021-03-10	Common Stock	S	6354	$190.08	Disposed	26911	Direct
2021-03-10	Common Stock	S	642	$191.33	Disposed	26269	Direct
2021-03-10	Common Stock	S	1004	$192.13	Disposed	25265	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2021-03-10	Stock Option (Right to Buy)	$33.05	M	2000	Disposed	2026-12-14	Common Stock (2000)	Direct
2021-03-10	Stock Option (Right to Buy)	$33.87	M	5850	Disposed	2028-03-01	Common Stock (5850)	Direct
2021-03-10	Stock Option (Right to Buy)	$59.52	M	150	Disposed	2029-02-28	Common Stock (150)	Direct

Footnotes

F1: $190.08 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $189.79 to $190.68, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.

F2: $191.33 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $190.79 to $191.75, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.

F3: $192.13 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $191.86 to $192.36, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.

F4: 8,000 of the shares underlying this option have vested. The remaining 2,000 shares shall vest on December 14, 2021.

F5: This option is fully vested and exercisable.

F6: 2,707 of the shares underlying this option have vested. The remaining 1,354 shares shall vest on February 28, 2022.